Skip to content
Screener

Carlsmed, Inc. CARL Q2 2025 earnings

Reported August 28, 2025 · After market close

Revenue$12.1MBeat by $95.8K
EPS-$1.47Beat by $0.05
Revenue estimate$12.0M
EPS estimate-$1.52

Next report

Nov 5, 2026 (in 3 months)
Revenue estimate$19.2M
EPS estimate-$0.42

Financials

Q2 2025

Income statement

See full
Revenue$12.1M+98.7%
Gross profit$8.9M+94.4%
Operating income-$6.5M-2.9%
Net income-$6.8M-7.8%
EPS (diluted)-$1.47+5.2%

Balance sheet

See full
Cash & equivalents$33.5M-12.3%
Total debt$17.7M—
Total equity-$83.1M-43.9%
Total assets$53.3M—

Cash flow

See full
Operating cash flow-$7.0M—
CapEx$327.0K—
Free cash flow-$7.4M—

Valuation & ratios

Profitability

See full
Gross margin74%—
Operating margin-64.5%—
Net margin-65.4%—
FCF margin-71.9%—

Returns & leverage

See full
Current ratio4.9×—

FAQ

When did Carlsmed, Inc. report Q2 2025 earnings?
Carlsmed, Inc. (CARL) reported Q2 2025 earnings on August 28, 2025 after market close.
What were Carlsmed, Inc.'s Q2 2025 revenue and EPS?
Carlsmed, Inc. reported revenue of $12.1M and eps of $-1.47 for Q2 2025.
Did Carlsmed, Inc. beat estimates in Q2 2025?
Revenue beat the consensus estimate of $12.0M by $95.8K. EPS beat the consensus estimate of $-1.52 by $0.05.
Where can I find Carlsmed, Inc.'s Q2 2025 SEC filings?
You can read the 8-K earnings release (0000950170-25-111947) and the 10-Q periodic report (0000950170-25-111953) directly on SEC EDGAR. The filing index links above go to sec.gov.